Cargando…
Large‐scale screening studies for atrial fibrillation – is it worth the effort?
Atrial fibrillation (AF) is a common disease with increasing prevalence, approximately 3.2% in the adult population. In addition, about one third of AF cases are considered asymptomatic. Due to increased longevity, increased detection and increased prevalence of risk factors, the prevalence of AF is...
Autores principales: | Engdahl, J., Rosenqvist, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048511/ https://www.ncbi.nlm.nih.gov/pubmed/33411987 http://dx.doi.org/10.1111/joim.13217 |
Ejemplares similares
-
Screening for atrial fibrillation: all invitees are equal, but some are more equal than others?
por: Engdahl, Johan, et al.
Publicado: (2023) -
Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation
por: Engdahl, Johan, et al.
Publicado: (2013) -
Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
por: Lyth, Johan, et al.
Publicado: (2022) -
Concomitant surgical ablation for atrial fibrillation (AF) in patients with significant atrial dilation >55 mm. Worth the effort?
por: Pecha, Simon, et al.
Publicado: (2015) -
Secondary Prevention of Atrial Fibrillation: Is It Worth Doing?
por: De Vecchis, Renato
Publicado: (2019)